MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations
The Singapore-based biotech company will evaluate its miRNA biomarker assay for early detection of pulmonary hypertension as part of the SPHERE study.
The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.
DiamiR Wins $3.9M in NIH Funding for Neurological Disease Diagnostic Development
The two grants awarded will support DiamiR's development of microRNA diagnostics for mild cognitive impairment, Alzheimer's disease, and Rett syndrome.
The firm recently published a study describing three assays for prostate cancer and reporting their sensitivity and specificity in case-control cohort.
Blood-Based MicroRNA Signatures Can Distinguish Individuals With Lung Cancer
A retrospective cohort study uncovered microRNA signatures that could tell lung cancer patients apart from others, including patients with other, non-tumor lung conditions.